Please SERD, I Want Some More (Molecular Degraders)
A session on molecular degraders at SABCS 2024 highlighted an exciting new frontier for SERDs, PROTACs, LYTACs, and biparatopic...
Category: Research
A session on molecular degraders at SABCS 2024 highlighted an exciting new frontier for SERDs, PROTACs, LYTACs, and biparatopic...
Researchers at the 2024 San Antonio Breast Cancer Symposium discussed considerations for treating and managing of early-onset breast cancer.
Iron can fuel cancer growth in many ways. Can researchers use tumors’ hunger for iron against them?
A recent study on the prevalence of cancer across different vertebrate species may provide insights into cancer mechanisms in...
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
Andrew Chapman and Kuang-Yi Wen of Thomas Jefferson University were named scientific awardees for their work in geriatric oncology...
Understanding pancreatic cancer’s strengths may provide clues to its weaknesses.
Researchers are exploring new combinations of therapy, disrupting iron accumulation, and turning tumors hot in attempts to make ovarian...
Recent advances in the genomics of childhood cancer may help inform potential causes and better treatment strategies.
Amidst an FDA investigation into secondary cancers after CAR T therapy, researchers show the risk is likely minimal.